These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro. Liu YC; Khawaja AM; Rogers DF Br J Pharmacol; 1999 Nov; 128(6):1353-9. PubMed ID: 10578152 [TBL] [Abstract][Full Text] [Related]
6. Neuropeptide-induced inhibition of IL-16 release from eosinophils. Dunzendorfer S; Feistritzer C; Enrich B; Wiedermann CJ Neuroimmunomodulation; 2002-2003; 10(4):217-23. PubMed ID: 12584409 [TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia. Delgado M; Jonakait GM; Ganea D Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366 [TBL] [Abstract][Full Text] [Related]
8. In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Ahmed AA; Wahbi A; Nordlind K; Kharazmi A; Sundqvist KG; Mutt V; Lidén S Scand J Immunol; 1998 Jul; 48(1):79-85. PubMed ID: 9714414 [TBL] [Abstract][Full Text] [Related]
9. Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis. Schratzberger P; Geiseler A; Dunzendorfer S; Reinisch N; Kähler CM; Wiedermann CJ J Neuroimmunol; 1998 Jul; 87(1-2):73-81. PubMed ID: 9670847 [TBL] [Abstract][Full Text] [Related]
10. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
12. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L; Ahrén B; Edgren G; Degerman E Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088 [TBL] [Abstract][Full Text] [Related]
13. Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro. Ogasawara M; Murata J; Ayukawa K; Saimi I Cancer Lett; 1997 Jun; 116(1):111-6. PubMed ID: 9177465 [TBL] [Abstract][Full Text] [Related]
14. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate. El-Shazly A; Masuyama K; Samejima Y; Eura M; Ishikawa T Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():10-3. PubMed ID: 9758889 [TBL] [Abstract][Full Text] [Related]
15. Effects of the three neuropeptides, vasoactive intestinal peptide, substance P, and calcitonin gene related peptide on basal and stimulated calcitonin release in the rat. Månsson B; Ahrén B; Nobin A Acta Endocrinol (Copenh); 1987 Jul; 115(3):297-300. PubMed ID: 2441551 [TBL] [Abstract][Full Text] [Related]
16. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients. Marie J; Wakkach A; Coudray A; Chastre E; Berrih-Aknin S; Gespach C J Immunol; 1999 Feb; 162(4):2103-12. PubMed ID: 9973484 [TBL] [Abstract][Full Text] [Related]
17. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells. Delgado M; Reduta A; Sharma V; Ganea D J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654 [TBL] [Abstract][Full Text] [Related]